TY  - JOUR
AU  - Haertle, Larissa
AU  - Buenache, Natalia
AU  - Cuesta Hernández, Hipólito Nicolás
AU  - Simicek, Michal
AU  - Snaurova, Renata
AU  - Rapado, Inmaculada
AU  - Martinez, Nerea
AU  - López Muñoz, María de las Nieves
AU  - Sánchez Pina, José María
AU  - Munawar, Umair
AU  - Han, Seungbin
AU  - Ruiz Heredia, Yanira
AU  - Colmenares Gil, Rafael
AU  - Gallardo Delgado, Miguel
AU  - Sanchez Beato, Margarita
AU  - Piris, Miguel Angel
AU  - Samur, Mehmet Kemal
AU  - Munshi, Nikhil C.
AU  - Ayala Díaz, Rosa María
AU  - Kortüm, Klaus Martin
AU  - Barrio, Santiago
AU  - Martínez López, Joaquín
PY  - 2023
DO  - 10.3390/cancers15020532
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.14352/72339
T2  - Cancers
AB  - For the treatment of Multiple Myeloma, proteasome inhibitors are highly efficient and widely used, but resistance is a major obstacle to successful therapy. Several underlying mechanisms have been proposed but were only reported for a minority of...
LA  - eng
M2  - 532
PB  - MDPI
KW  - Multiple Myeloma
KW  - Drug resistance
KW  - Proteasome inhibitors
KW  - PSMC2
KW  - Immunoglobulin rearrangement
KW  - ATPase activity
TI  - Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
TY  - journal article
VL  - 15
ER  -